(Q41029394)

25 September 2017

Pharmacokinetic studies in animals and humans of a new cephalosporin, the sodium salt of 7-cyanacetamidocephalosporanic acid (English)

1 reference

25 September 2017

1 reference

Luscombe DK

1

1 reference

25 September 2017

Nicholls PJ

series ordinal

2

1 reference

25 September 2017

Owens DR

series ordinal

3

1 reference

25 September 2017

Russell AD

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 June 1973

1 reference

Antimicrobial Agents and Chemotherapy

25 September 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

25 September 2017

3

1 reference

25 September 2017

6

1 reference

25 September 2017

677-681

1 reference

Interaction of a New Cephalosporin, 7-Cyanacetamidocephalosporanic Acid, with Some Gram-Negative and Gram-Positive β-Lactamase-Producing Bacteria

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444479

PubMed Central

reference URL

Preliminary studies of serum levels and the excretion of a new cephalosporin derivative, the sodium salt of 7-cyanoacetamido-cephalosporanic acid (CIBA 36,278A-Ba) in normal human subjects and rabbits

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444479

PubMed Central

reference URL

Antimicrobial studies in vitro with CIBA 36278-Ba, a new cephalosporin derivative

26 September 2017

1 reference

https://pubmed.ncbi.nlm.nih.gov/4208297

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.3.6.677

1 reference

25 September 2017

1 reference

25 September 2017

PubMed publication ID

4208297

1 reference